Nitric oxide biology
Published literature describes nitric oxide across signaling, immune response, microbial burden, and tissue repair.
Investors & partners
NOxy combines patented point-of-care foam generation, the NOX1416 clinical program, peer-reviewed laboratory and real-world research, and a team with wound-care, clinical, scientific, engineering, and operating experience.
Program foundation
Published literature describes nitric oxide across signaling, immune response, microbial burden, and tissue repair.
Two components combine as a topical foam and generate nitric oxide at application.
Clinical development, retrospective analysis, tissue models, laboratory assays, and reviews are reported separately.
The team brings wound-care, clinical, scientific, engineering, and operating experience.
Partnering
NOxy welcomes conversations with investors, strategic partners, clinical researchers, and organizations working on hard-to-heal wounds.
Identify your area of interest so we can route your inquiry to the appropriate NOxy team member.
Contact the team